Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited
1 Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
2 Division of Urology, VCU Health, Richmond, VA, USA.
3 Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
4 Helen Diller Family Comprehensive Cancer Center, Departments of Urology and Epidemiology & Biostatistics, University of California-San Francisco, San Francisco, CA, USA.
5 Unit of Urology, Ospedale ASST Sette Laghi, Varese, Italy.
6 Unit of Urology, EOC Ospedale Regionale di Lugano, Università della Svizzera Italiana, Lugano, Switzerland.
7 Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
8 Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, MI, USA; Division of Urology, Spectrum Health Hospital System, Grand Rapids, MI, USA.
9 Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, Ancona, Italy.
10 Department of Urology, Ludwig-Maximilians University of Munich, Munich, Germany.
11 Service d'Urologie, Cliniques universitaires Saint Luc, Université catholique de Louvain, Brussels, Belgium.
12 Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: montorsi.francesco@hsr.it.